These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 1863620
1. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)]. Borobio MV, Domínguez MC, Pallares JA, Perea EJ. Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620 [Abstract] [Full Text] [Related]
3. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group. Bremmelgaard A, Jansen JE, Justesen T, Gottschau A. APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792 [Abstract] [Full Text] [Related]
5. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Snydman DR, Jacobus NV, McDermott LA, Golan Y, Hecht DW, Goldstein EJ, Harrell L, Jenkins S, Newton D, Pierson C, Rihs JD, Yu VL, Venezia R, Finegold SM, Rosenblatt JE, Gorbach SL. Clin Infect Dis; 2010 Jan 01; 50 Suppl 1():S26-33. PubMed ID: 20067390 [Abstract] [Full Text] [Related]
6. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility]. Rodríguez E, Gamboa MM, Rodríguez C, Vargas P. Rev Esp Quimioter; 2006 Dec 01; 19(4):357-62. PubMed ID: 17235405 [Abstract] [Full Text] [Related]
7. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Snydman DR, McDermott L, Cuchural GJ, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL. Clin Infect Dis; 1996 Dec 01; 23 Suppl 1():S54-65. PubMed ID: 8953108 [Abstract] [Full Text] [Related]
8. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJ, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Yu V, Rihs J, Gorbach SL. Antimicrob Agents Chemother; 2007 May 01; 51(5):1649-55. PubMed ID: 17283189 [Abstract] [Full Text] [Related]
9. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Betriu C, Culebras E, Gómez M, López F, Rodríguez-Avial I, Picazo JJ. Antimicrob Agents Chemother; 2008 Jul 01; 52(7):2686-90. PubMed ID: 18474575 [Abstract] [Full Text] [Related]
11. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain. García-Rodríguez JE, García-Sánchez JE. Rev Infect Dis; 1990 Jul 01; 12 Suppl 2():S142-51. PubMed ID: 2305180 [Abstract] [Full Text] [Related]
15. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)]. Rokosz A, Pawłowska J, Sawicka-Grzelak A, Luczak M. Med Dosw Mikrobiol; 2004 Jul 01; 56(3):245-53. PubMed ID: 15773501 [Abstract] [Full Text] [Related]
16. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Bandoh K, Ueno K, Watanabe K, Kato N. Clin Infect Dis; 1993 Jun 01; 16 Suppl 4():S382-6. PubMed ID: 8324152 [Abstract] [Full Text] [Related]
17. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan. Watanabe K, Ueno K, Kato N, Muto Y, Bandoh K, Tanaka Y, Jotwani R, Goto M, Shimada K, Shimizu K. Eur J Clin Microbiol Infect Dis; 1992 Nov 01; 11(11):1069-73. PubMed ID: 1295761 [Abstract] [Full Text] [Related]